Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia.
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, United Kingdom.
Mucosal Immunol. 2019 Mar;12(2):299-311. doi: 10.1038/s41385-018-0130-4. Epub 2019 Jan 21.
Group 2 innate lymphoid cells (ILC2s) are a recently described subset of innate lymphocytes with important immune and homeostatic functions at multiple tissue sites, especially the lung. These cells expand locally after birth and during postnatal lung maturation and are present in the lung and other peripheral organs. They are modified by a variety of processes and mediate inflammatory responses to respiratory pathogens, inhaled allergens and noxious particles. Here, we review the emerging roles of ILC2s in pulmonary homeostasis and discuss recent and surprising advances in our understanding of how hormones, age, neurotransmitters, environmental challenges, and infection influence ILC2s. We also review how these responses may underpin the development, progression and severity of pulmonary inflammation and chronic lung diseases and highlight some of the remaining challenges for ILC2 biology.
第 2 组先天淋巴细胞 (ILC2) 是最近描述的先天淋巴细胞亚群,在多个组织部位(尤其是肺部)具有重要的免疫和体内平衡功能。这些细胞在出生后和出生后肺成熟期间局部扩增,并存在于肺部和其他外周器官中。它们受到多种过程的修饰,并介导对呼吸道病原体、吸入性过敏原和有害颗粒的炎症反应。在这里,我们回顾了 ILC2 在肺内稳态中的新兴作用,并讨论了我们对激素、年龄、神经递质、环境挑战和感染如何影响 ILC2 的理解的最新和令人惊讶的进展。我们还回顾了这些反应如何构成肺部炎症和慢性肺部疾病的发展、进展和严重程度的基础,并强调了 ILC2 生物学的一些遗留挑战。